Total Payments
$6,863
2024 Payments
$1,024
Companies
35
Transactions
519
Medicare Patients
18,351
Medicare Billing
$1.6M
Payment Breakdown by Category
Food & Beverage$6,863 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,863 | 519 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $1,869 | 217 | $0 (2024) |
| GlaxoSmithKline, LLC. | $916.23 | 45 | $0 (2024) |
| Allergan, Inc. | $518.39 | 43 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $476.57 | 23 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $367.04 | 7 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $356.64 | 33 | $0 (2024) |
| ABBVIE INC. | $272.98 | 14 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $187.58 | 10 | $0 (2024) |
| Novo Nordisk Inc | $183.94 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $172.37 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,024 | 50 | PFIZER INC. ($221.70) |
| 2023 | $1,100 | 49 | PFIZER INC. ($220.38) |
| 2022 | $698.36 | 50 | GlaxoSmithKline, LLC. ($243.52) |
| 2021 | $955.81 | 58 | PFIZER INC. ($244.32) |
| 2020 | $819.19 | 52 | PFIZER INC. ($343.76) |
| 2019 | $792.69 | 81 | PFIZER INC. ($299.18) |
| 2018 | $751.54 | 89 | PFIZER INC. ($202.47) |
| 2017 | $720.77 | 90 | Allergan Inc. ($277.19) |
All Payment Transactions
519 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/21/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/08/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $6.48 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/07/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $4.52 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/15/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $2.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/09/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Obesity | ||||||
| 09/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: RESPIRATORY | ||||||
| 09/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/17/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 09/05/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: Diabetes | ||||||
| 08/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/23/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $8.31 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $11.01 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 06/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Oncology | ||||||
| 06/11/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.94 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/07/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.42 | General |
| Category: Inflammation | ||||||
| 06/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $27.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/30/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: GI | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 4,628 | 7,942 | $711,120 | $418,905 |
| 2022 | 27 | 4,509 | 7,363 | $691,755 | $407,655 |
| 2021 | 29 | 4,543 | 7,098 | $663,044 | $388,403 |
| 2020 | 29 | 4,671 | 7,196 | $683,499 | $350,339 |
Total Patients
18,351
Total Services
29,599
Medicare Billing
$1.6M
Procedure Codes
111
All Medicare Procedures & Services
111 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 992 | 2,226 | $233,730 | $144,794 | 61.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 570 | 901 | $135,150 | $82,852 | 61.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 550 | 550 | $88,000 | $73,612 | 83.7% |
| G0181 | Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 2023 | 92 | 249 | $37,350 | $20,530 | 55.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 1,001 | 1,969 | $39,380 | $16,525 | 42.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 59 | 162 | $28,350 | $16,108 | 56.8% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 550 | 550 | $27,500 | $10,467 | 38.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 60 | 65 | $14,625 | $9,393 | 64.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 87 | 87 | $20,445 | $8,595 | 42.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $7,800 | $4,924 | 63.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 32 | $8,640 | $4,636 | 53.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 26 | 26 | $5,200 | $4,457 | 85.7% |
| 99235 | Initial hospital care with same-day admission and discharge with moderate level of medical decision making, per day, if using time, at least 70 minutes | Facility | 2023 | 13 | 25 | $6,250 | $3,319 | 53.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 83 | 83 | $2,905 | $2,683 | 92.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 27 | 27 | $5,400 | $2,586 | 47.9% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 59 | 71 | $7,100 | $2,564 | 36.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 60 | 229 | $9,160 | $2,379 | 26.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 47 | 49 | $3,675 | $1,987 | 54.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 83 | 83 | $5,395 | $1,818 | 33.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 47 | 98 | $3,430 | $1,590 | 46.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 24 | 24 | $4,680 | $1,453 | 31.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 19 | 19 | $1,385 | $642.25 | 46.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 26 | 26 | $1,300 | $421.20 | 32.4% |
| 90471 | Administration of vaccine | Office | 2023 | 18 | 20 | $700.00 | $332.00 | 47.4% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 54 | 225 | $11,250 | $228.07 | 2.0% |
About Dr. Beata Styka, M.D
Dr. Beata Styka, M.D is a Geriatric Medicine healthcare provider based in Palos Heights, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275623233.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Beata Styka, M.D has received a total of $6,863 in payments from pharmaceutical and medical device companies, with $1,024 received in 2024. These payments were reported across 519 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($6,863).
As a Medicare-enrolled provider, Styka has provided services to 18,351 Medicare beneficiaries, totaling 29,599 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 111 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Location Palos Heights, IL
- Active Since 10/13/2006
- Last Updated 03/23/2020
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1275623233
Products in Payments
- ELIQUIS (Drug) $1,037
- TRELEGY ELLIPTA (Drug) $866.25
- CHANTIX (Drug) $690.85
- XARELTO (Drug) $476.57
- Trintellix (Drug) $333.50
- VRAYLAR (Drug) $257.36
- REXULTI (Drug) $224.28
- AIRSUPRA (Drug) $204.79
- UBRELVY (Drug) $171.24
- TRINTELLIX (Drug) $152.83
- SPIRIVA RESPIMAT (Drug) $143.87
- Ozempic (Drug) $113.55
- NAMZARIC (Drug) $110.18
- ENTRESTO (Drug) $108.95
- Vascepa (Drug) $107.55
- BREZTRI (Drug) $92.41
- MYRBETRIQ (Drug) $85.83
- VOQUEZNA (Drug) $80.06
- JANUVIA (Drug) $77.07
- MOUNJARO (Drug) $77.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.